OncoSec Medical Incorporated announced the addition of two new executives to the company's management team. Industry veteran Brian Leuthner has been appointed as OncoSec's Chief Operating Officer and Joe Smith has joined as Vice President of Business Development. Mr. Leuthner joins OncoSec having held a variety of leadership positions over his 32 year biotech and pharmaceutical career, including CEO and Chief Operating Officer functions. Joining OncoSec as Vice President of Business Development, Mr. Smith was most recently an independent transaction advisor and acting Head of Business Development to a number of biotechnology and specialty pharmaceutical companies, including an antibody-focused start-up, an orphan ophthalmology specialty business and a vaccine technology business focused on COVID-19.